S&P 500   4,953.71 (-0.44%)
DOW   38,428.16 (-0.35%)
QQQ   423.52 (-0.89%)
AAPL   181.14 (-0.23%)
MSFT   399.39 (-0.84%)
META   467.59 (-0.78%)
GOOGL   142.23 (+0.79%)
AMZN   168.30 (+0.73%)
TSLA   194.20 (+0.23%)
NVDA   674.39 (-2.90%)
NIO   6.09 (+2.18%)
AMD   163.60 (-1.26%)
BABA   75.62 (+3.39%)
T   16.92 (+0.06%)
F   12.10 (-1.22%)
MU   80.45 (-0.32%)
CGC   3.40 (-3.95%)
GE   148.35 (-0.18%)
DIS   107.66 (-1.63%)
AMC   4.55 (-2.36%)
PFE   27.45 (-0.51%)
PYPL   57.51 (-1.91%)
XOM   104.89 (+2.08%)
S&P 500   4,953.71 (-0.44%)
DOW   38,428.16 (-0.35%)
QQQ   423.52 (-0.89%)
AAPL   181.14 (-0.23%)
MSFT   399.39 (-0.84%)
META   467.59 (-0.78%)
GOOGL   142.23 (+0.79%)
AMZN   168.30 (+0.73%)
TSLA   194.20 (+0.23%)
NVDA   674.39 (-2.90%)
NIO   6.09 (+2.18%)
AMD   163.60 (-1.26%)
BABA   75.62 (+3.39%)
T   16.92 (+0.06%)
F   12.10 (-1.22%)
MU   80.45 (-0.32%)
CGC   3.40 (-3.95%)
GE   148.35 (-0.18%)
DIS   107.66 (-1.63%)
AMC   4.55 (-2.36%)
PFE   27.45 (-0.51%)
PYPL   57.51 (-1.91%)
XOM   104.89 (+2.08%)
S&P 500   4,953.71 (-0.44%)
DOW   38,428.16 (-0.35%)
QQQ   423.52 (-0.89%)
AAPL   181.14 (-0.23%)
MSFT   399.39 (-0.84%)
META   467.59 (-0.78%)
GOOGL   142.23 (+0.79%)
AMZN   168.30 (+0.73%)
TSLA   194.20 (+0.23%)
NVDA   674.39 (-2.90%)
NIO   6.09 (+2.18%)
AMD   163.60 (-1.26%)
BABA   75.62 (+3.39%)
T   16.92 (+0.06%)
F   12.10 (-1.22%)
MU   80.45 (-0.32%)
CGC   3.40 (-3.95%)
GE   148.35 (-0.18%)
DIS   107.66 (-1.63%)
AMC   4.55 (-2.36%)
PFE   27.45 (-0.51%)
PYPL   57.51 (-1.91%)
XOM   104.89 (+2.08%)
S&P 500   4,953.71 (-0.44%)
DOW   38,428.16 (-0.35%)
QQQ   423.52 (-0.89%)
AAPL   181.14 (-0.23%)
MSFT   399.39 (-0.84%)
META   467.59 (-0.78%)
GOOGL   142.23 (+0.79%)
AMZN   168.30 (+0.73%)
TSLA   194.20 (+0.23%)
NVDA   674.39 (-2.90%)
NIO   6.09 (+2.18%)
AMD   163.60 (-1.26%)
BABA   75.62 (+3.39%)
T   16.92 (+0.06%)
F   12.10 (-1.22%)
MU   80.45 (-0.32%)
CGC   3.40 (-3.95%)
GE   148.35 (-0.18%)
DIS   107.66 (-1.63%)
AMC   4.55 (-2.36%)
PFE   27.45 (-0.51%)
PYPL   57.51 (-1.91%)
XOM   104.89 (+2.08%)

Forte Biosciences (FBRX) Earnings Date, Estimates & Call Transcripts

$0.70
0.00 (0.00%)
(As of 02:08 PM ET)

Earnings Summary

Upcoming
Earnings Date
Mar. 29Estimated
Actual EPS
(Nov. 13)
-$0.26 Missed By -$0.26
Skip Charts & View Estimated and Actual Earnings Data

FBRX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

FBRX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Forte Biosciences Analyst EPS Estimates

Current Year EPS Consensus Estimate:($0.58) EPS
Next Year EPS Consensus Estimate: ($0.63) EPS

FBRX Earnings Date and Information

Forte Biosciences last released its quarterly earnings results on November 13th, 2023. The reported ($0.26) EPS for the quarter. Forte Biosciences has generated ($1.24) earnings per share over the last year (($1.24) diluted earnings per share). Earnings for Forte Biosciences are expected to decrease in the coming year, from ($0.58) to ($0.63) per share. Forte Biosciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, March 29th, 2024 based off prior year's report dates.

Forte Biosciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
3/29/2024
Estimated)
------- 
11/13/2023Q3 2023-($0.26)($0.26)($0.26)--
8/14/2023Q2 2023-($0.42)($0.42)($0.42)--
5/15/2023Q1 2023-($0.32)($0.32)($0.32)--
3/31/2023Q4 2022-($0.24)($0.24)($0.24)--
11/14/2022Q3 2022-($0.18)($0.18)($0.18)--
8/15/2022Q2 2022-($0.21)($0.21)($0.21)--
5/16/2022Q1 2022-($0.17)($0.17)($0.17)--
3/31/2022Q4 2021-($0.21)($0.21)($0.21)--
11/18/2021Q3($0.36)($0.54)($0.18)($0.54)--    
11/8/2021Q3 2021($0.29)($0.54)($0.25)($0.54)--
8/16/2021Q2 2021($0.40)($0.43)($0.03)($0.43)--
5/9/2021Q1 2021($0.39)($0.36)+$0.03($0.36)--  
3/24/2021Q4 2020($0.49)($0.37)+$0.12---  












Forte Biosciences Earnings - Frequently Asked Questions

When is Forte Biosciences's earnings date?

Forte Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, March 29th, 2024 based off last year's report dates. Learn more on FBRX's earnings history.

How much profit does Forte Biosciences generate each year?

Forte Biosciences (NASDAQ:FBRX) has a recorded net income of -$13.88 million. FBRX has generated -$1.24 earnings per share over the last four quarters.

What is Forte Biosciences's EPS forecast for next year?

Forte Biosciences's earnings are expected to decrease from ($0.58) per share to ($0.63) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:FBRX) was last updated on 2/21/2024 by MarketBeat.com Staff